{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T03:55:25Z","timestamp":1770350125103,"version":"3.49.0"},"reference-count":45,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Genet."],"abstract":"<jats:p>Thiamine metabolism dysfunction syndrome 2 (THMD2) is a rare metabolic disorder caused by <jats:italic>SLC19A3<\/jats:italic> mutations, inherited in autosomal recessive pattern. As a treatable disease, early diagnosis and therapy with vitamin supplementation is important to improve the prognosis. So far, the reported cases were mainly from Saudi Arab regions, and presented with relatively simple clinical course because of the hot spot mutation (T422A). Rare Chinese cases were described until now. In this study, we investigated 18 Chinese THMD2 patients with variable phenotypes, and identified 23 novel <jats:italic>SLC19A3<\/jats:italic> mutations, which expanded the genetic and clinical spectrum of the disorder. Meanwhile, we reviewed all 146 reported patients from different countries. Approximately 2\/3 of patients presented with classical BTBGD, while 1\/3 of patients manifested as much earlier onset and poor prognosis, including infantile Leigh-like syndrome, infantile spasms, neonatal lactic acidosis and infantile BTBGD. Literature review showed that elevated lactate in blood and CSF, as well as abnormal OXPHOS activities of muscle or skin usually correlated with infantile phenotypes, which indicated poor outcome. Brainstem involvement on MRI was more common in deceased cases. Thiamine supplementation is indispensable in the treatment of THMD2, whereas combination of biotin and thiamine is not superior to thiamine alone. But biotin supplementation does work in some patients. Genotypic-phenotypic correlation remains unclear which needs further investigation, and biallelic truncated mutations usually led to more severe phenotype.<\/jats:p>","DOI":"10.3389\/fgene.2021.683255","type":"journal-article","created":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T15:52:26Z","timestamp":1625154746000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":18,"title":["Report of the Largest Chinese Cohort With SLC19A3 Gene Defect and Literature Review"],"prefix":"10.3389","volume":"12","author":[{"given":"Jiaping","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junling","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaodi","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhimei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanli","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guohong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haoya","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruifeng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuqin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongxin","family":"Wen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinhua","family":"Bao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,7,1]]},"reference":[{"key":"B1","first-page":"228","article-title":"Biotin responsive limb weakness.","volume":"44","author":"Adhisivam","year":"2007","journal-title":"Indian Pediatr."},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1177\/1179573517737521","article-title":"Early infantile leigh-like SLC19A3 gene defects have a poor prognosis: report and review.","volume":"9","author":"Alfadhel","year":"2017","journal-title":"J. Cent. Nerv. Syst. Dis."},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-8-83","article-title":"Biotin-responsive basal ganglia disease should be renamed biotin-thiamine-responsive basal ganglia disease: a retrospective review of the clinical, radiological and molecular findings of 18 new cases.","volume":"8","author":"Alfadhel","year":"2013","journal-title":"Orphanet J. Rare Dis."},{"key":"B4","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1055\/s-0037-1607191","article-title":"SLC19A3 gene defects sorting the phenotype and acronyms: review.","volume":"49","author":"Alfadhel","year":"2018","journal-title":"Neuropediatrics"},{"key":"B5","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1080\/01616412.2016.1263176","article-title":"Biotin-thiamine-responsive basal ganglia disease: catastrophic consequences of delay in diagnosis and treatment.","volume":"39","author":"Algahtani","year":"2017","journal-title":"Neurol. Res."},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000004819","article-title":"A case report of biotin-thiamine-responsive basal ganglia disease in a Saudi child: Is extended genetic family study recommended?","volume":"95","author":"Aljabri","year":"2016","journal-title":"Medicine"},{"key":"B7","doi-asserted-by":"publisher","first-page":"e71","DOI":"10.1212\/WNL.0000000000002372","article-title":"Teaching NeuroImages: MRI findings of biotin-responsive basal ganglia disease before and after treatment.","volume":"86","author":"Bin Saeedan","year":"2016","journal-title":"Neurology"},{"key":"B8","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1177\/0883073808329525","article-title":"Biotin-responsive basal ganglia disease: a treatable and reversible neurological disorder of childhood.","volume":"24","author":"Bindu","year":"2009","journal-title":"J. Child Neurol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"223","DOI":"10.5582\/ddt.2016.01046","article-title":"Depression in adult patients with biotin responsive basal ganglia disease.","volume":"10","author":"Bubshait","year":"2016","journal-title":"Drug Discov. Ther."},{"key":"B10","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1001\/archneurol.2009.293","article-title":"Biotin-responsive basal ganglia disease in ethnic Europeans with novel SLC19A3 mutations.","volume":"67","author":"Debs","year":"2010","journal-title":"Arch. Neurol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/8904_2013_271","article-title":"Biotin-responsive Basal Ganglia disease: a treatable differential diagnosis of leigh syndrome.","volume":"13","author":"Distelmaier","year":"2014","journal-title":"JIMD Rep."},{"key":"B12","doi-asserted-by":"publisher","first-page":"2376","DOI":"10.1056\/NEJMcpc1706109","article-title":"Case 38-2017. A 20-Year-Old Woman with Seizures and Progressive Dystonia.","volume":"377","author":"Eichler","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1055\/s-0028-1128152","article-title":"Biotin-responsive basal ganglia disease: case report and review of the literature.","volume":"39","author":"El-Hajj","year":"2008","journal-title":"Neuropediatrics"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2013-200838","article-title":"Treatable Leigh-like encephalopathy presenting in adolescence.","volume":"2013","author":"Fassone","year":"2013","journal-title":"BMJ Case Rep."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1002\/ajmg.a.38189","article-title":"Biotin-thiamine responsive basal ganglia disease: identification of a pyruvate peak on brain spectroscopy, novel mutation in SLC19A3, and calculation of prevalence based on allele frequencies from aggregated next-generation sequencing data.","volume":"173","author":"Ferreira","year":"2017","journal-title":"Am. J. Med. Genet. A"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0149055","article-title":"Novel SLC19A3 promoter deletion and allelic silencing in biotin-thiamine-responsive basal ganglia encephalopathy.","volume":"11","author":"Flones","year":"2016","journal-title":"PLoS One"},{"key":"B17","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1007\/s00424-003-1068-1","article-title":"SLC19: the folate\/thiamine transporter family.","volume":"447","author":"Ganapathy","year":"2004","journal-title":"Pflugers Arch."},{"key":"B18","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1093\/brain\/awt013","article-title":"Exome sequencing reveals a novel Moroccan founder mutation in SLC19A3 as a new cause of early-childhood fatal Leigh syndrome.","volume":"136","author":"Gerards","year":"2013","journal-title":"Brain"},{"key":"B19","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s12098-017-2471-5","article-title":"Biotin thiamin responsive basal ganglia disease in siblings.","volume":"85","author":"Gowda","year":"2018","journal-title":"Indian J. Pediatr."},{"key":"B20","doi-asserted-by":"publisher","first-page":"e295","DOI":"10.1093\/brain\/awu128","article-title":"Infantile Leigh-like syndrome caused by SLC19A3 mutations is a treatable disease.","volume":"137","author":"Haack","year":"2014","journal-title":"Brain"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.3174\/ajnr.A3966","article-title":"Biotin-responsive basal ganglia disease: neuroimaging features before and after treatment.","volume":"35","author":"Kassem","year":"2014","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1093\/brain\/awt054","article-title":"Exome sequencing reveals mutated SLC19A3 in patients with an early-infantile, lethal encephalopathy.","volume":"136","author":"Kevelam","year":"2013","journal-title":"Brain"},{"key":"B23","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/jhg.2015.35","article-title":"Biotin-responsive basal ganglia disease: a case diagnosed by whole exome sequencing.","volume":"60","author":"Kohrogi","year":"2015","journal-title":"J. Hum. Genet."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1056\/NEJMc0809100","article-title":"Mutations in a thiamine-transporter gene and Wernicke\u2019s-like encephalopathy.","volume":"360","author":"Kono","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmg.2020.104003","article-title":"Eleven novel mutations and clinical characteristics in seven Chinese patients with thiamine metabolism dysfunction syndrome.","volume":"63","author":"Li","year":"2020","journal-title":"Eur. J. Med. Genet."},{"key":"B26","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1002\/ana.24998","article-title":"Thiamine deficiency in childhood with attention to genetic causes: survival and outcome predictors.","volume":"82","author":"Ortigoza-Escobar","year":"2017","journal-title":"Ann. Neurol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1093\/brain\/awv342","article-title":"Free-thiamine is a potential biomarker of thiamine transporter-2 deficiency: a treatable cause of Leigh syndrome.","volume":"139","author":"Ortigoza-Escobar","year":"2016","journal-title":"Brain"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-9-92","article-title":"Thiamine transporter-2 deficiency: outcome and treatment monitoring.","volume":"9","author":"Ortigoza-Escobar","year":"2014","journal-title":"Orphanet J. Rare Dis."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1093\/brain\/121.7.1267","article-title":"Biotin-responsive basal ganglia disease: a novel entity.","volume":"121","author":"Ozand","year":"1998","journal-title":"Brain"},{"key":"B30","doi-asserted-by":"publisher","first-page":"e1670","DOI":"10.1542\/peds.2012-2988","article-title":"Reversible lactic acidosis in a newborn with thiamine transporter-2 deficiency.","volume":"131","author":"Perez-Duenas","year":"2013","journal-title":"Pediatrics"},{"key":"B31","doi-asserted-by":"publisher","first-page":"146","DOI":"10.5114\/fn.2017.68581","article-title":"Neuropathological characteristics of the brain in two patients with SLC19A3 mutations related to the biotin-thiamine-responsive basal ganglia disease.","volume":"55","author":"Pronicki","year":"2017","journal-title":"Folia Neuropathol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1055\/s-0038-1676603","article-title":"Biotin-thiamine responsive encephalopathy: report of an Egyptian family with a novel SLC19A3 mutation and review of the literature.","volume":"8","author":"Savasta","year":"2019","journal-title":"J. Pediatr. Genet."},{"key":"B33","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1111\/bpa.12117","article-title":"Stress-induced upregulation of SLC19A3 is impaired in biotin-thiamine-responsive basal ganglia disease.","volume":"24","author":"Schanzer","year":"2014","journal-title":"Brain Pathol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"e184","DOI":"10.1212\/WNL.0000000000002616","article-title":"Teaching NeuroImages: biotin-responsive basal ganglia disease.","volume":"86","author":"Schwarting","year":"2016","journal-title":"Neurology"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1002\/mds.25008","article-title":"Reversible generalized dystonia and encephalopathy from thiamine transporter 2 deficiency.","volume":"27","author":"Serrano","year":"2012","journal-title":"Mov. Disord."},{"key":"B36","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.ymgmr.2014.07.008","article-title":"Whole exome sequencing reveals compound heterozygous mutations in SLC19A3 causing biotin-thiamine responsive basal ganglia disease.","volume":"1","author":"Sremba","year":"2014","journal-title":"Mol. Genet. Metab. Rep."},{"key":"B37","doi-asserted-by":"publisher","first-page":"C851","DOI":"10.1152\/ajpcell.00105.2006","article-title":"Biotin-responsive basal ganglia disease-linked mutations inhibit thiamine transport via hTHTR2: biotin is not a substrate for hTHTR2.","volume":"291","author":"Subramanian","year":"2006","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.ejpn.2015.05.008","article-title":"Treatment of biotin-responsive basal ganglia disease: open comparative study between the combination of biotin plus thiamine versus thiamine alone.","volume":"19","author":"Tabarki","year":"2015","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1212\/WNL.0b013e31827deb4c","article-title":"Biotin-responsive basal ganglia disease revisited: clinical, radiologic, and genetic findings.","volume":"80","author":"Tabarki","year":"","journal-title":"Neurology"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1016\/j.jpeds.2012.12.069","article-title":"Bilateral external ophthalmoplegia in biotin-responsive basal ganglia disease.","volume":"162","author":"Tabarki","year":"","journal-title":"J. Pediatr."},{"key":"B41","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.ejpn.2017.11.012","article-title":"SLC19A3 related disorder: treatment implication and clinical outcome of 2 new patients.","volume":"22","author":"Tonduti","year":"2018","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1101\/mcs.a001909","article-title":"Compound heterozygous SLC19A3 mutations further refine the critical promoter region for biotin-thiamine-responsive basal ganglia disease.","volume":"3","author":"Whitford","year":"2017","journal-title":"Cold Spring Harb. Mol. Case Stud."},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2350-11-171","article-title":"A wide spectrum of clinical and brain MRI findings in patients with SLC19A3 mutations.","volume":"11","author":"Yamada","year":"2010","journal-title":"BMC Med. Genet."},{"key":"B44","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.ejpn.2016.01.009","article-title":"Biotin and thiamine responsive basal ganglia disease\u2013A vital differential diagnosis in infants with severe encephalopathy.","volume":"20","author":"Ygberg","year":"2016","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1086\/431216","article-title":"Biotin-responsive basal ganglia disease maps to 2q36.3 and is due to mutations in SLC19A3.","volume":"77","author":"Zeng","year":"2005","journal-title":"Am. J. Hum. Genet."}],"container-title":["Frontiers in Genetics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2021.683255\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T15:52:30Z","timestamp":1625154750000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2021.683255\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,1]]},"references-count":45,"alternative-id":["10.3389\/fgene.2021.683255"],"URL":"https:\/\/doi.org\/10.3389\/fgene.2021.683255","relation":{},"ISSN":["1664-8021"],"issn-type":[{"value":"1664-8021","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,1]]},"article-number":"683255"}}